We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $71.3B
1-Year Est. Return 56.8%
This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
Cap. Flow
-$2.43B
Cap. Flow %
-3.41%
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$353M
2
MRVL icon
Marvell Technology
MRVL
+$150M
3
SYRE icon
Spyre Therapeutics
SYRE
+$126M
4
BBIO icon
BridgeBio Pharma
BBIO
+$116M
5
DOV icon
Dover
DOV
+$110M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$713M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$355M
3
CTRA
Coterra Energy
CTRA
+$289M
4
RPRX icon
Royalty Pharma
RPRX
+$259M
5
LLY icon
Eli Lilly
LLY
+$236M

Sector Composition

Rank Sector Weight
1 Technology 32.29%
2 Healthcare 14.03%
3 Financials 12.39%
4 Industrials 8.94%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLTR icon
51
Palantir
PLTR
$407B
$239M 0.34%
2,047,700
+1,300
+0.1% +$177K
JCI icon
52
Johnson Controls International
JCI
$87.8B
$238M 0.33%
1,631,713
+116,037
+8% +$16.4M
LIN icon
53
Linde
LIN
$215B
$235M 0.33%
452,335
-1,000
-0.2% -$506K
OVV icon
54
Ovintiv
OVV
$17.8B
$230M 0.32%
4,372,109
-535,000
-11% -$30.5M
VNOM icon
55
Viper Energy
VNOM
$16.3B
$230M 0.32%
5,426,609
+421,919
+8% +$19.5M
WFC icon
56
Wells Fargo
WFC
$271B
$226M 0.32%
2,729,296
-40,200
-1% -$3.23M
MRVL icon
57
Marvell Technology
MRVL
$211B
$222M 0.31%
+745,800
New +$150M
GS icon
58
Goldman Sachs
GS
$300B
$219M 0.31%
216,089
+761
+0.4% +$742K
TXN icon
59
Texas Instruments
TXN
$239B
$215M 0.3%
721,644
-71,400
-9% -$19.8M
ABT icon
60
Abbott
ABT
$182B
$212M 0.3%
2,332,115
+624,351
+37% +$57M
TMO icon
61
Thermo Fisher Scientific
TMO
$224B
$204M 0.29%
406,154
-139,678
-26% -$67.1M
WDC icon
62
Western Digital
WDC
$174B
$196M 0.28%
307,437
+13,700
+5% +$6.66M
VRTX icon
63
Vertex Pharmaceuticals
VRTX
$132B
$196M 0.27%
393,964
+141,974
+56% +$62.9M
MS icon
64
Morgan Stanley
MS
$338B
$194M 0.27%
929,034
-43,700
-4% -$8.65M
STX icon
65
Seagate
STX
$201B
$193M 0.27%
200,000
+14,600
+8% +$11.1M
ANET icon
66
Arista Networks
ANET
$243B
$188M 0.26%
1,105,900
+180,800
+20% +$28.4M
AJG icon
67
Arthur J. Gallagher & Co
AJG
$62.6B
$183M 0.26%
799,003
+458,240
+134% +$97.3M
TNGX icon
68
Tango Therapeutics
TNGX
$4.05B
$175M 0.25%
5,600,000
-7,209,485
-56% -$178M
CRWD icon
69
CrowdStrike
CRWD
$213B
$171M 0.24%
897,600
+74,400
+9% +$10.6M
AMGN icon
70
Amgen
AMGN
$212B
$171M 0.24%
471,833
+129,333
+38% +$44.3M
CVS icon
71
CVS Health
CVS
$122B
$170M 0.24%
1,639,209
+42,579
+3% +$3.8M
QCOM icon
72
Qualcomm
QCOM
$188B
$168M 0.24%
910,021
-45,800
-5% -$8.56M
BBIO icon
73
BridgeBio Pharma
BBIO
$14.9B
$168M 0.24%
2,252,000
+1,653,000
+276% +$116M
UAL icon
74
United Airlines
UAL
$34.8B
$163M 0.23%
1,198,242
+983,533
+458% +$102M
C icon
75
Citigroup
C
$231B
$159M 0.22%
1,136,086
+240,600
+27% +$31.3M
1 2
3
4 5

Similar funds

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Adage Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.

  • Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
  • Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
  • Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
  • Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
  • Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
  • Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.